Search results
Moderna sues Pfizer, BioNTech over COVID-19 vaccine patents
WFXT via Yahoo News· 2 years agoCOVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main...
This 1 Number Could Completely Change Your Opinion of Moderna
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) exploded onto the scene when it began development of its coronavirus vaccine....
Moderna Is Suing Pfizer And BioNTech, Alleging They Stole mRNA Technology For COVID Vaccines
BuzzFeed News via Yahoo News· 2 years agoModerna on Friday filed twin lawsuits in US federal court and in Germany against rivals Pfizer and...
Moderna combo COVID-19/flu vaccine succeeds in early-stage trial
Reuters via Yahoo Finance· 7 months agoModerna on Wednesday said its combination vaccine to protect against both COVID-19 and influenza...
Moderna COVID vaccine sales forecasts fall short for 2022, 2023
Reuters via Yahoo Finance· 2 years ago(Reuters) -Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory...
Better Buy Ahead of FDA Meetings: Moderna vs. Novavax
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) both delivered major returns for investors in the...
Hitting the Books: How Moderna dialed-in its vaccine to fight COVID's variants
Engadget· 2 years agoIn "The Messenger," veteran reporter Peter Loftus takes readers through the harrowing days of 2020...
Does This News From Switzerland Mean Trouble for Moderna?
Motley Fool· 2 years agoWhen coronavirus vaccines first hit the market, countries couldn't get enough of them to meet...
Moderna To Develop mRNA Vaccines in China
Motley Fool· 10 months agoFor more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 5 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...
